SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Charts for Quick CASH $$$
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: N/E PATSFAN who wrote (6490)2/28/1998 5:31:00 AM
From: SnowShredder  Read Replies (1) of 9262
 
I think that SUPG is a company that has great management. The founder of Amgen knows how to make a biotech company grow and succeed. And with an experienced board they are bound for success. My guess is that they are trying to become profitable as soon as possible by producing generic drugs. This will give them a steady cash flow to fund the expensive trial on their hopeful blockbuster drugs...thus they won't need to seek additional funding. Instead of spending a lot of $ on doing there own research, I think they license out technology from smaller biotech companies in need of funding. It has been a while since I looked @ the company, but I hope that this helps.

Another promising biotech company is LGND, they are supposed to file an NDA this quarter and they have many collaborations with major Pharmaceuticals. They are expected to be profitable by next year. SI has a very good thread if you want more info.

Best of Luck Trading,

Where'd He Go?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News